Maoto plus neuraminidase inhibitor versus neuraminidase inhibitor alone for reducing hospitalization in older adults with seasonal influenza-Reference-Cited by-同舟云学术

Maoto plus neuraminidase inhibitor versus neuraminidase inhibitor alone for reducing hospitalization in older adults with seasonal influenza

Published:2022 Issue:4 Volume:4 Page:120-128
ISSN:2434-4338
Container-title:Annals of Clinical Epidemiology
language:en
Short-container-title:Ann Clin Epidemiol

Author:

Yamana Hayato¹,Sasabuchi Yusuke²,Matsui Hiroki³,Michihata Nobuaki¹,Jo Taisuke¹,Yasunaga Hideo³

Affiliation:

1. Department of Health Services Research, Graduate School of Medicine, The University of Tokyo

2. Data Science Center, Jichi Medical University

3. Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo

Publisher

Society for Clinical Epidemiology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/ace/4/4/4_22015/_pdf

Reference27 articles.

1. 1. Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ 2016;355:i6258.

2. 2. World Health Organization. Global Influenza Strategy 2019–2030. Available from: https://apps.who.int/iris/handle/10665/311184, Accessed 2022 Mar 7.

3. 3. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018;391:1285–1300.

4. 4. Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1305–1309.

5. 5. Lee L, Butt K, Buckrell S, Nwosu A, Sevenhuysen C, Bancej C. National influenza mid-season report, 2020–2021. Can Commun Dis Rep 2021;47:1–4.